-
EP2494483
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2494483
| EP2494483 - METHOD FOR DETERMINING RISK OF DIABETES [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 07.09.2018 Database last updated on 19.03.2026 | Most recent event Tooltip | 07.09.2018 | Withdrawal of application | published on 10.10.2018 [2018/41] | Applicant(s) | For all designated states Health Diagnostic Laboratory, Inc. 737 N 5th Street Suite 103 Richmond, VA 23219 / US | [2014/37] |
| Former [2012/36] | For all designated states Tethys Bioscience, Inc. 5858 Horton Street, Suite 550 Emeryville, CA 94608-2917 / US | Inventor(s) | 01 /
MCKENNA, Michael, P. 280 41st Street Oakland CA 94611 / US | 02 /
ROWE, Michael 6463 Irwin Court Oakland CA 94609 / US | 03 /
MOLER, Edward, J., Jr. 943 Meander Drive Walnut Creek CA 94598 / US | 04 /
GERWIEN, Robert, W. 56 Francis Avenue Newington CT 06111 / US | [2012/36] | Representative(s) | Marshall, Cameron John Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
| Former [2012/36] | Marshall, Cameron John Carpmaels & Ransford One Southampton Row London WC1B 5HA / GB | Application number, filing date | 10779365.5 | 28.10.2010 | WO2010US54397 | Priority number, date | US20090256286P | 29.10.2009 Original published format: US 256286 P | [2012/36] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2011059720 | Date: | 19.05.2011 | Language: | EN | [2011/20] | Type: | A2 Application without search report | No.: | EP2494483 | Date: | 05.09.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 19.05.2011 takes the place of the publication of the European patent application. | [2012/36] | Search report(s) | International search report - published on: | EP | 30.06.2011 | Classification | IPC: | G06F19/24, G06F19/18 | [2012/36] | CPC: |
G16B40/00 (EP,US);
G16B20/20 (EP,US);
G16B40/30 (EP,US);
G16H50/20 (US);
G16H50/30 (US);
G16B20/00 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2012/36] | Title | German: | VERFAHREN ZUR BESTIMMUNG DES DIABETESRISIKOS | [2012/36] | English: | METHOD FOR DETERMINING RISK OF DIABETES | [2012/36] | French: | MÉTHODE DE DÉTERMINATION DU RISQUE DE DIABÈTE | [2012/36] | Entry into regional phase | 29.05.2012 | National basic fee paid | 29.05.2012 | Designation fee(s) paid | 29.05.2012 | Examination fee paid | Examination procedure | 29.05.2012 | Examination requested [2012/36] | 26.02.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | 08.05.2013 | Amendment by applicant (claims and/or description) | 31.08.2018 | Application withdrawn by applicant [2018/41] | Request for further processing for: | 08.05.2013 | Request for further processing filed | 08.05.2013 | Full payment received (date of receipt of payment) Request granted | 20.06.2013 | Decision despatched | Fees paid | Renewal fee | 12.02.2013 | Renewal fee patent year 03 | 10.04.2014 | Renewal fee patent year 04 | 14.10.2014 | Renewal fee patent year 05 | 25.02.2016 | Renewal fee patent year 06 | 11.10.2016 | Renewal fee patent year 07 | 11.10.2017 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 31.10.2012 | 03 M06 Fee paid on 12.02.2013 | 31.10.2013 | 04 M06 Fee paid on 10.04.2014 | 31.10.2015 | 06 M06 Fee paid on 25.02.2016 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [I] US2009012716 (URDEA MICHAEL S et al.) | by applicant | US2007218519 | US2007259377 | US2009012716 | US4727022 | US4659678 | US4376110 | US4275149 | US4233402 | US4230767 | US2002038227 | US2004122296 | US2004122297 | US5018067 | "The American Diabetes Association addresses the diagnosis and classification of Diabetes", DIABETES CARE, vol. 32, no. 1, 2009, pages S62 - S67 | DIABETES CARE, vol. 33, no. I, 2010, pages S62 - S69 | "Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications", WORLD HEALTH ORGANIZATION, 1999 | O'MARCAIGH AS; JACOBSON RM: "Estimating The Predictive Value Of A Diagnostic Test, How To Prevent Misleading Or Confusing Results", CLIN. PED., vol. 32, no. 8, 1993, pages 485 - 491 | PEPE ET AL.: "Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic, Prognostic, or Screening Marker", AM. J. EPIDEMIOL, vol. 159, no. 9, 2004, pages 882 - 890, XP055013965, DOI: doi:10.1093/aje/kwh101 DOI: http://dx.doi.org/10.1093/aje/kwh101 | SHULTZ: "Teitz, Fundamentals of Clinical Chemistry", 1996, W.B. SAUNDERS COMPANY, article "Clinical Interpretation Of Laboratory Procedures", pages: 192 - 199 | ZWEIG ET AL.: "ROC Curve Analysis: An Example Showing The Relationships Among Serum Lipid And Apolipoprotein Concentrations In Identifying Subjects With Coronory Artery Disease", CLIN. CHEM., vol. 38, no. 8, 1992, pages 1425 - 1428 | COOK: "Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction", CIRCULATION, vol. 115, 2007, pages 928 - 935 | VASAN: "Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations", CIRCULATION, vol. 113, 2006, pages 2335 - 2362 | VASAN, CIRCULATION, vol. 113, 2006, pages 2335 - 2362 | C. SPEARMAN: "The proof and measurement of association between two things", AMER. J. PSYCHOL., vol. 15, 1904, pages 72 - 101, XP008104419, DOI: doi:10.2307/1412159 DOI: http://dx.doi.org/10.2307/1412159 | CORDER: "Nonparametric Statistics for Non-Statisticians: A Step-by-Step Approach", 2009, WILEY | ABRAMOWITZ ET AL.: "Handbook of Mathematical Functions with Formulas, Graphs, and Mathematical Tables", 1965 | "Engineering Statistics Handbook - Chi-Square Distribution", 2006 | JOHNSON ET AL.: "Continuous Univariate Distributions", vol. 1, 1994, WILLEY AND SONS | MOOD ET AL.: "Introduction to the Theory of Statistics", 1974, MCGRAW-HILL, pages: 241 - 246 | E. MAGGIO: "Enzyme-lmmunoassay", 1980, CRC PRESS, INC. | WIRTH, U. ET AL., PROTEOMICS, vol. 2, no. 10, 2002, pages 1445 - 51 | WILSON, C. ET AL.: "Clinical Chemistry Analyzer Sub-System Level Performance", AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY ANNUAL MEETING, Retrieved from the Internet | KISNER HJ: "Product development: the making of the Abbott ARCHITECT", CLIN LAB MANAGE REV., vol. 11, no. 6, November 1997 (1997-11-01), pages 419 - 2 1 | OGNIBENE A ET AL.: "A new modular chemiluminescence immunoassay analyser evaluated", CLIN CHEM LAB MED., vol. 38, no. 3, March 2000 (2000-03-01), pages 251 - 60 | PARK JW ET AL.: "Three-year experience in using total laboratory automation system", SOUTHEAST ASIAN J TROP MED PUBLIC HEALTH., vol. 33, no. 2, 2002, pages 68 - 73 | PAULI D ET AL.: "The Abbott Architect c8000: analytical performance and productivity characteristics of a new analyzer applied to general chemistry testing", CLIN LAB., vol. 51, no. 1-2, 2005, pages 31 - 41 | "Randox Daytona Operator Manual Version 1.6 Rev.", May 2005 |